Evidence map›Paper›PMID 33916370›Full record

ArticleCancers2021

Permeability of

Elżbieta Studzińska-Sroka, Aleksandra Majchrzak-Celińska, Przemysław Zalewski, Dominik Szwajgier, Ewa Baranowska-Wójcik, Marcin Żarowski, Tomasz Plech, Judyta Cielecka-Piontek

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
9.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Butenolides and triterpenoids from the fungusFrontiers in fungal biology · 2026
    Article
  3. Article
  4. Cyclodextrin-Based Systems ofMolecules (Basel, Switzerland) · 2025
    Article
  5. Article
  6. Article
  7. Biomolecules · 2024
    Review
  8. Article
  9. Green Extraction of Depsidones and Depsides fromInternational journal of molecular sciences · 2024
    Article
  10. Article
  11. Review
  12. How Does Radiation Affect Curcumin Raw Material?International journal of molecular sciences · 2024
    Article
  13. Article
  14. Pleiotropic Potential ofMolecules (Basel, Switzerland) · 2023
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Elżbieta Studzińska-SrokaDepartment of Pharmacognosy, Poznan University of Medical Sciences, Święcicki 4 Str, 60-781 Poznań, Poland.ORCID 0000-0002-0462-1766
Aleksandra Majchrzak-CelińskaDepartment of Pharmaceutical Biochemistry, Poznan University of Medical Sciences, Święcicki 4 Str, 60-781 Poznań, Poland.ORCID 0000-0002-2872-8875
Przemysław ZalewskiDepartment of Pharmacognosy, Poznan University of Medical Sciences, Święcicki 4 Str, 60-781 Poznań, Poland.ORCID 0000-0002-5116-9426
Dominik SzwajgierDepartment of Biotechnology, Microbiology and Human Nutrition, University of Life Sciences in Lublin, Skromna 8 Str, 20-704 Lublin, Poland.ORCID 0000-0002-2285-0669
Ewa Baranowska-WójcikDepartment of Biotechnology, Microbiology and Human Nutrition, University of Life Sciences in Lublin, Skromna 8 Str, 20-704 Lublin, Poland.ORCID 0000-0002-2213-9631
Marcin ŻarowskiDepartment of Developmental Neurology, Poznan University of Medical Sciences, Przybyszewski 49 Str, 60-355 Poznań, Poland.ORCID 0000-0002-9800-9446
Tomasz PlechDepartment of Pharmacology, Medical University of Lublin, Chodźki 4a Str, Lublin, Poland.ORCID 0000-0002-8162-8435
Judyta Cielecka-PiontekDepartment of Pharmacognosy, Poznan University of Medical Sciences, Święcicki 4 Str, 60-781 Poznań, Poland.ORCID 0000-0003-0891-5419
Poznan University of Medical Sciences · PLUniversity of Life Sciences in Lublin · PLMedical University of Lublin · PL

Funding

Narodowe Centrum Nauki UMO- 2020/37/B/NZ7/03975
6 · The paper itself

Abstract

Lichen secondary metabolites are characterized by huge pharmacological potential. Our research focused on assessing the anticancer and neuroprotective activity of

Indexed as

anticancerblood–brain barrier permeabilitychemopreventive and neuroprotective activityHypogymnia physodes

Identifiers

PMID33916370
PMCPMC8038629
OpenAlexW3151419324

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.